edelstein & company LLP

160 federal st 9th flr
boston, massachusetts 02110

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 02, 2014

NYS DOS ID#
4645465

County

Jurisdiction
MASSACHUSETTS

Registered Agent
NONE

NYS Entity Type
FOREIGN REGISTERED LIMITED LIABILITY PARTNERSHIP

Name History
2014 - EDELSTEIN & COMPANY LLP









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • DataCamp Nabs $4M for Data Science Courses, Moves to NY
    By Jeff Engel - Thursday Jul 27, 2017

    Data scientists remain in high demand. But these days, many types of professionals can boost their career prospects if they have at least a basic level of “data literacy,” says Jonathan Cornelissen. That’s part of the reason why he says his online education company, DataCamp, has been growing over the past couple of years. DataCamp, […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Join Tesaro and Others at Boston’s Life Science Disruptors Sept. 28
    By Jacquie Ogonowsky - Thursday Jul 13, 2017

    For the fifth year in a row, Xconomy will hold our fall Boston life sciences event, “Boston’s Life Science Disruptors”, on Thursday September 28th at Pfizer in Kendall Square in Cambridge. Join us for this unique event featuring candid stories from some of New England’s most radical biotech company leaders, founders, and VC backers who […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Monday Jun 19, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy VC, Deals, & Startups Feed
  • CarGurus Drives Off With $150M in Boston’s First Tech IPO of 2017
    By Jeff Engel - Thursday Oct 12, 2017

    [Updated 10/12/17, 10:20 am. See below.] Amid another sluggish year for tech IPOs, advocates of Boston’s tech scene can breathe a sigh of relief—the area won’t be shut out this year. CarGurus and its stockholders raised about $150.4 million in the company’s initial public offering, marking the Boston area’s first tech IPO of 2017. The Cambridge, […]

    Source: Xconomy VC, Deals, & Startups Feed